Lamictal (Lamotrigine)

Lamotrigine blocks voltage‑gated sodium channels on nerve cells, which reduces the release of excitatory neurotransmitters such as glutamate. By dampening this neuronal over‑activity, the drug helps control seizure activity and contributes to mood stabilization in bipolar disorder.

The dose of Lamictal is individualized and set by the prescribing clinician based on the patient’s condition, age, and response to therapy. Starting doses are typically low and increased gradually to minimise the risk of skin reactions, with the final dose determined by therapeutic goals and tolerability.

Safety data for lamotrigine in pregnancy and lactation are limited. It may be used when the benefits outweigh potential risks, but clinicians usually discuss possible teratogenic effects and monitor fetal development closely. Lamotrigine does pass into breast milk, so breastfeeding decisions should be made with medical guidance.

To order Lamictal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with carbamazepine, another common antiepileptic, lamotrigine has a lower risk of drug‑induced hyponatraemia and fewer cognitive side effects, but it requires slower titration to avoid skin reactions. Against valproic acid, lamotrigine offers a more favourable weight‑gain profile but may be less effective for certain generalized seizure types.

Lamictal should be stored at ambient temperature, ideally below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date printed on the label.

Lamictal is taken orally, usually as a tablet or dispersible tablet. It should be swallowed whole with water and can be taken with or without food. Patients should follow the prescriber’s titration schedule and avoid crushing or chewing the tablets unless specifically instructed.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, which require immediate medical attention if a rash appears. Other critical concerns are blood dyscrasias, hepatic dysfunction, and the emergence of suicidal thoughts or behavior, especially during treatment initiation or dose changes.

Lamictal is contraindicated in individuals with a known hypersensitivity to lamotrigine or any of its excipients. Patients with severe hepatic impairment should avoid use, and those with a history of serious skin reactions to other medications should be evaluated carefully before starting therapy.